APA (7th ed.) Citation

Clemence Pouzin, Michel Tod, Mustapha Chadjaa, Nathalie Fagniez, & Laurent Nguyen. (2022). Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CEACAM5 antibody‐drug conjugate, based on first‐in‐human study. Wiley.

Chicago Style (17th ed.) Citation

Clemence Pouzin, Michel Tod, Mustapha Chadjaa, Nathalie Fagniez, and Laurent Nguyen. Covariate Analysis of Tusamitamab Ravtansine, a DM4 Anti‐CEACAM5 Antibody‐drug Conjugate, Based on First‐in‐human Study. Wiley, 2022.

MLA (9th ed.) Citation

Clemence Pouzin, et al. Covariate Analysis of Tusamitamab Ravtansine, a DM4 Anti‐CEACAM5 Antibody‐drug Conjugate, Based on First‐in‐human Study. Wiley, 2022.